Eitan Medical UK Limited Filleted Accounts Cover |
Audited accounts | |||||||||
Company No. 12738832 | |||||||||
Eitan Medical UK Limited Directors Report Registrar |
The Directors present their report and the accounts for the year ended 31 December 2024. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
S. Eitan | (Appointed on 27 June 2024) | ||||||||
G.Y. Hadar | |||||||||
I. Shany | (Resigned 1 January 2024) | ||||||||
S. Sharoni | (Resigned 27 June 2024) | ||||||||
Auditors | |||||||||
The auditors, Gordon Levy Limited, will be proposed for appointment in accordance with Section 486 of the Companies Act 2006. | |||||||||
Signed on behalf of the board | |||||||||
G.Y. Hadar | |||||||||
Director | |||||||||
04 September 2025 | |||||||||
Eitan Medical UK Limited Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2024 | 2023 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 4 | |||||||||
Current assets | ||||||||||
Stocks | 5 | |||||||||
Debtors | 6 | |||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 7 | ( | ( | |||||||
Net current liabilities | ( | ( | ||||||||
Total assets less current liabilities | ( | ( | ||||||||
Net liabilities | ( | ( | ||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 8 | ( | ( | |||||||
Total equity | ( | ( | ||||||||
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006. | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 04 September 2025 and signed on its behalf by: | ||||||||||
G.Y. Hadar | ||||||||||
Director | ||||||||||
04 September 2025 | ||||||||||
Eitan Medical UK Limited Notes to the Accounts Registrar |
for the year ended 31 December 2024 | ||||||||||||||||
1 | General information | |||||||||||||||
Eitan Medical UK Limited is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||||
The company's registered number is: 12738832 | ||||||||||||||||
The address of the company's registered office is: | ||||||||||||||||
2 | Accounting policies | |||||||||||||||
Turnover | ||||||||||||||||
Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||||
Furniture, fittings and equipment | ||||||||||||||||
Taxation | ||||||||||||||||
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively. | ||||||||||||||||
Stocks | ||||||||||||||||
Stocks are stated at the lower of cost and net realisable value. Net realisable value is based upon estimated selling prices less further costs expected to be incurred to disposal. | ||||||||||||||||
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the statement of comprehensive income. | ||||||||||||||||
Trade and other debtors | ||||||||||||||||
Trade and other creditors | ||||||||||||||||
Foreign currencies | ||||||||||||||||
Judgements and key sources of estimation uncertainty | ||||||||||||||||
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. | ||||||||||||||||
Financial instruments | ||||||||||||||||
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable. | ||||||||||||||||
Cash and cash equivalents | ||||||||||||||||
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. | ||||||||||||||||
Operating leases: as lessee | ||||||||||||||||
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term. Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset. | ||||||||||||||||
Financial assets | ||||||||||||||||
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is identified, an impairment loss is recognised in profit or loss. | ||||||||||||||||
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. | ||||||||||||||||
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and its recoverable amount, which is an estimate of the amount that the company would receive for the asset if it were to be sold at the reporting date. | ||||||||||||||||
Defined contribution pensions | ||||||||||||||||
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds. | ||||||||||||||||
Going concern | ||||||||||||||||
These financial statements have been prepared on a going concern basis. The director, having considered the financial position of the company for a period of at least twelve months from the date of signing these financial statements, has no reason to believe that a material uncertainty exists that may cast doubt about the ability of the company to continue as a going concern. Accordingly the director has a reasonable expectation that the company will continue in operational existence and therefore he continues to adopt the going concern basis of accounting to prepare the financial statements. | ||||||||||||||||
3 | Employees | |||||||||||||||
2024 | 2023 | |||||||||||||||
Number | Number | |||||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||||
4 | Tangible fixed assets | |||||||||||||||
Fixtures, fittings and equipment | Total | |||||||||||||||
£ | £ | |||||||||||||||
Cost or revaluation | ||||||||||||||||
At 1 January 2024 | ||||||||||||||||
Additions | ||||||||||||||||
At 31 December 2024 | ||||||||||||||||
Depreciation | ||||||||||||||||
At 1 January 2024 | ||||||||||||||||
Charge for the year | ||||||||||||||||
At 31 December 2024 | ||||||||||||||||
Net book values | ||||||||||||||||
At 31 December 2024 | ||||||||||||||||
At 31 December 2023 | 175 | |||||||||||||||
5 | Stocks | |||||||||||||||
2024 | 2023 | |||||||||||||||
£ | £ | |||||||||||||||
Finished goods | ||||||||||||||||
6 | Debtors | |||||||||||||||
2024 | 2023 | |||||||||||||||
£ | £ | |||||||||||||||
Trade debtors | ||||||||||||||||
Deferred tax asset | ||||||||||||||||
Other debtors | ||||||||||||||||
Prepayments and accrued income | ||||||||||||||||
7 | Creditors: | |||||||||||||||
amounts falling due within one year | ||||||||||||||||
2024 | 2023 | |||||||||||||||
£ | £ | |||||||||||||||
Trade creditors | ||||||||||||||||
Taxes and social security | ||||||||||||||||
Other creditors | ||||||||||||||||
Accruals and deferred income | ||||||||||||||||
8 | Reserves | |||||||||||||||
9 | Guarantees and commitments | |||||||||||||||
2024 | 2023 | |||||||||||||||
£ | £ | |||||||||||||||
Total of guarantees and commitments | ||||||||||||||||
10 | Related party disclosures | |||||||||||||||
Transactions with related parties | ||||||||||||||||
The company has taken advantage of the exemption available according to FRS 102 1A "Related party disclosure" not to disclose transactions entered into between two or more members of a group that are wholly owned. | ||||||||||||||||
Ultimate controlling party | ||||||||||||||||
The ultimate parent undertaking is Eitan Medical Ltd, a company incorporated in Israel, whose principal place of business is 29 Yad Haruzim St. PO Box 8639, Netanya, 4250529, Israel. | ||||||||||||||||
Parent Company | ||||||||||||||||
The name of the parent of the smallest group for which consolidated financial statements are drawn up of which this entity is a member: | ||||||||||||||||
Eitan Medical Ltd | ||||||||||||||||
The parent's registered office address is: | ||||||||||||||||
29 Yad Haruzim St. | ||||||||||||||||
P.O. Box 8639 | ||||||||||||||||
Netanya | ||||||||||||||||
4250529 Israel | ||||||||||||||||
11 | Audit of the accounts | |||||||||||||||
Unqualified | ||||||||||||||||
The auditors were: Gordon Levy Limited | Gordon Levy Limited | |||||||||||||||
The senior statutory auditor was: Gordon Levy BA, FCA | ||||||||||||||||